Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ana Carolina Giuseppi"'
Autor:
Matteo Giovanni Della Porta, Uwe Platzbecker, Valeria Santini, Amer M. Zeidan, Pierre Fenaux, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna Jonášová, Sophie Dimicoli-Salazar, Ing Soo Tiong, Chien-Chin Lin, Jiahui LI, Jennie Zhang, Ana Carolina Giuseppi, Sandra Kreitz, Veronika Pozharskaya, Karen L. Keeperman, Shelonitda Rose, Jeevan K. Shetty, Sheida Hayati, Sadanand Vodala, Andrius Degulys, Stefania Paolini, Thomas Cluzeau, Guillermo Garcia-Manero
Publikováno v:
HemaSphere, Vol 7, p e999540c (2023)
Externí odkaz:
https://doaj.org/article/2535aa49593e45caac3cb3cea134730d
Autor:
Aaron T. Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Alessandro Vannucchi, Rami S. Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam Mead, Jason Gotlib, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne Palmer, Kelly Mccaul, Vincent Ribrag, Srdan Verstovsek, Francesco Passamonti
Publikováno v:
HemaSphere, Vol 7, p e0882611 (2023)
Externí odkaz:
https://doaj.org/article/c45032cc341b4a4c9484e09d00786e90
Autor:
Nianhang Chen, Nastya Kassir, Abderrahmane Laadem, Stephen E. Maxwell, Priya Sriraman, Ana Carolina Giuseppi, Steve Ritland, Peter G. Linde, Balasubrahmanyam Budda, Joseph G. Reynolds, Simon Zhou, Maria Palmisano
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 7, Pp 395-404 (2020)
Luspatercept is a recombinant fusion protein that enhances late‐stage erythroid maturation. This report describes the population pharmacokinetics and exposure–response relationship of luspatercept in 260 patients with anemia due to myelodysplasti
Externí odkaz:
https://doaj.org/article/b71c1d3971b14218bd2a4fcb5ebcb47a
Autor:
Daniel W. Coyne, Hem N. Singh, William T. Smith, Ana Carolina Giuseppi, Jamie N. Connarn, Matthew L. Sherman, Frank Dellanna, Hartmut H. Malluche, Keith A. Hruska
Publikováno v:
Kidney International Reports, Vol 4, Iss 11, Pp 1585-1597 (2019)
Introduction: Patients with end-stage kidney disease (ESKD) exhibit anemia, chronic kidney disease‒mineral bone disorder (CKD–MBD), and cardiovascular disease. The REN-001 and REN-002 phase II, multicenter, randomized studies examined safety, tol
Externí odkaz:
https://doaj.org/article/0bccf5654da24b36b96c0047fa7d3a78
Autor:
Simon Zhou, Priya Sriraman, Ana Carolina Giuseppi, Stephen E. Maxwell, Balasubrahmanyam Budda, Peter G. Linde, Steve Ritland, Maria Palmisano, Joseph G. Reynolds, Nianhang Chen, Abderrahmane Laadem, Nastya Kassir
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 7, Pp 395-404 (2020)
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology
Luspatercept is a recombinant fusion protein that enhances late-stage erythroid maturation. This report describes the population pharmacokinetics and exposure-response relationship of luspatercept in 260 patients with anemia due to myelodysplastic sy
Autor:
Balasubrahmanyam Budda, Nianhang Chen, Jeevan K. Shetty, Nastya Kassir, Ana Carolina Giuseppi, Steve Ritland, Maria Palmisano, Joseph G. Reynolds, Peter G. Linde, Priya Sriraman, Abderrahmane Laadem, Simon Zhou, Stephen E. Maxwell
Publikováno v:
Journal of Clinical Pharmacology
β‐Thalassemia is an inherited blood disorder resulting from defects in hemoglobin production, leading to premature death of red blood cells (RBCs) or their precursors. Patients with transfusion‐dependent β‐thalassemia often need lifelong regu
Autor:
Ali T Taher, Maria Domenica Cappellini, Antonis Kattamis, Ersi Voskaridou, Silverio Perrotta, Antonio G Piga, Aldo Filosa, John B Porter, Thomas D Coates, Gian Luca Forni, Alexis A Thompson, Immacolata Tartaglione, Khaled M Musallam, Jay T Backstrom, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Dimana Miteva, Jennifer Lord-Bessen, Aylin Yucel, Tatiana Zinger, Jeevan K Shetty, Vip Viprakasit, Jassada Buaboonnam, Supachai Ekwattanakit, Archrob Khunhapinant, Efthalia Loka, Maria Moraki, Pagona Flevari, Maria Dimopoulou, Vasiliki Bartzi, Hisham Daadaa, Georges El Hasbani, Suzanne Koussa, Federica Ammendola, Saverio Scianguetta, Marta Puglia, Ilaria Ferrara, Giovanni Ferrero, Carmen Gaglioti, Filomena Longo, Silvia Turrini, Vincenzo Voi, Elena Cassinerio, Anna De, Giovanna Graziadei, Alessia Marcon, Margherita Migone De Amicis, Irene Motta, Patrizia Cinque, Bruno Pannone, Paolo Ricchi, Manuela Balocco, Paola Carrara, Francesco Della Rovere, Martina Lamagna, Valeria Pinto, Sabrina Quintino, Perla Eleftheriou, Maciej Garbowski, Arne de Kreuk, Susan Carson, Christopher Denton, Tom Hofstra, Sayany Veluswamy, John Wood, Sherif Badawy, Rachel Bercovitz, Rukhmi Bhat, Diane Calamaras, Robert Liem, Astrid Mack
Background In patients with non-transfusion-dependent beta-thalassaemia, haemoglobin concentrations lower than 10 g/dL are associated with a higher risk of morbidity, mortality, and impaired quality of life. No drugs are specifically approved for ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee0b05dfe2f212574c84ccff10e5f0f
https://hdl.handle.net/11591/497789
https://hdl.handle.net/11591/497789
Autor:
Jennie Zhang, Adam J. Mead, Srdan Verstovsek, Giovanni Barosi, Ana Carolina Giuseppi, Marina Kremyanskaya, Martin Schwickart, Jeevan K. Shetty, Vincent Ribrag, Joseph Pariseau, Claire N. Harrison, Gabriel Miranda, Kelly McCaul, Jay Backstrom, Torsten G. Gerike, Jeanne Palmer, Jason Gotlib, Alessandro M. Vannucchi, Francesco Passamonti, Ruben A. Mesa, Jean-Jacques Kiladjian, Aaron T. Gerds
Publikováno v:
Blood. 136:47-48
Introduction: MF is a clonal stem cell disorder characterized by progressive bone marrow failure, extramedullary hematopoiesis, and debilitating constitutional symptoms. Approximately 60% of pts develop anemia within a year of diagnosis; pts who are